Preparing Clinicians for Complex Airway Disease

Preparing the Next Generation of Clinicians for Complex Airway Disease

July 7, 2026

Why Airway Disease Education Requires Interdisciplinary Training

Chronic rhinosinusitis (CRS), asthma, eosinophilic inflammation, and nasal polyposis often coexist because they share underlying inflammatory pathways, particularly type 2–mediated immune responses, rather than occurring as independent processes. When upper and lower airway diseases are managed independently, common immunologic drivers and coordinated treatment strategies may be overlooked. Airway disease education that integrates the shared inflammatory pathways and frequent coexistence of these conditions is essential to comprehensive patient care.

Why Interdisciplinary Training Produces Better Diagnostic Accuracy

Otolaryngologists, allergists, pulmonologists, and primary care physicians all encounter conditions that cross anatomical and clinical specialty lines, yet most residency programs continue structuring airway disease education around specific medical specialties. ENT multidisciplinary training equips clinicians with a comprehensive foundation in shared airway disease management early in their careers, before incomplete diagnostic approaches become entrenched in clinical practice.

Biologics and Phenotyping: A Critical Knowledge Gap

Biologic therapy is one of the fastest evolving areas in airway medicine, yet many physicians enter independent practice unprepared or underprepared to prescribe it confidently. Clinician education in CRS must include structured training in eosinophil phenotyping and biologic selection, two areas rarely covered with adequate depth in standard airway disease education programs.

Several biologic therapies are FDA approved for the treatment of severe asthma, including omalizumab, mepolizumab, reslizumab, benralizumab, dupilumab, tezepelumab, and depemokimab. Several biologics are also FDA approved for chronic rhinosinusitis with nasal polyps (CRSwNP), and additional biologic therapies are under investigation for asthma, CRS, and other inflammatory airway diseases. As the use of these agents continues to expand, multidisciplinary education in biologic therapies is becoming an increasingly important component of otolaryngology training.

Simulation and Case-Based Learning Improves Clinical Diagnosis

Simulation, case-based learning, and multidisciplinary conferences convert knowledge into diagnostic precision and treatment accuracy. ENT multidisciplinary training models uniting otolaryngology, allergy, and pulmonology specialties in shared clinical settings have shown particular promise in building diagnostic accuracy and treatment confidence.

Priority research areas include head-to-head biologic comparisons, cost-effectiveness analysis, standardized protocols for biologic initiation, dose adjustment and discontinuation, and the integration of biologic therapy with endoscopic sinus surgery and biomarker-driven precision medicine.

The Role of Research Collaboration in Clinical Development

Integrating research participation into airway disease education produces clinicians who approach diagnosis and treatment with greater rigor and intellectual depth. The direct cost of CRS in the U.S. is estimated at between $10 and $13 billion per year, with indirect costs from lost productivity exceeding $20 billion annually.

The increasing complexity of airway disease diagnosis and treatment has consistently outpaced the clinician education CRS training needed to address it. Cross-specialty research collaboration between otolaryngology, allergy, and pulmonology is essential to closing that gap. Shared investigative work across these disciplines generates more clinically relevant findings than any single specialty can produce independently, and exposes physicians to the full diagnostic and therapeutic spectrum of airway disease.

Institutions that integrate cross-specialty research partnerships graduate clinicians better prepared to interpret emerging data, evaluate new biologics critically, and apply precision medicine principles essential for improving patient outcomes.

Raising the Standard for Complex Airway Disease Training

The Snot Force Alliance was created to mobilize specialists from multiple disciplines to collaborate, share research, and improve outcomes. To learn more about the clinicians working to raise that standard, visit Snotforce.org.

< Older Post

Newer Post >

Rural and Underserved Access to Multidisciplinary Airway Expertise

September 22, 2026

Inflammatory airway diseases can impact a patient's quality of life. Untreated conditions leave patients struggling to breathe, coughing regularly, and feeling unwell for months at a time. Airway disease management has undergone significant changes in recent years. Treating airway diseases has become increasingly complex, despite improvements in methodologies and technologies. In rural and underserved regions, many patients lack access to specialty care. Key Takeaways: Providing high-quality care to patients with airway disease requires collaboration across specialties. It is important to expand rural ENT access and access to multidisciplinary clinics. Clinicians in rural communities can improve patient outcomes through collaborations and with creative solutions that expand airway care. The Need for Multidisciplinary Airway Care Airway diseases affect multiple systems of the body and thus are treated by different types of physicians. Allergists, primary care doctors, pulmonologists, and ENT physicians all play a role in caring for patients with airway conditions. Physicians who can facilitate multidisciplinary care can improve diagnostic accuracy while also helping to ensure better patient outcomes. Challenges in Rural and Underserved Communities Rural ENT access is spotty at best. Many rural areas lack specialty physicians and often, patients must travel long distances to tertiary medical centers where they receive care. As a result, patients with limited transportation options may experience delays in diagnosis and care. Sometimes, these specialty care disparities can leave primary care providers to manage complex airway conditions on their own. In areas where insurance coverage is limited, and referral networks are fragmented, patients may struggle with their conditions without treatment at all. The Consequences of These Limitations Delays in diagnosis and treatment mean poor management of chronic conditions and increased reliance on treatment from acute care settings. Under this system, patients become frustrated as they lean on ineffective treatment methods. Methods for Expanding Access There are many methods for expanding access to patients in rural and underserved areas. Telehealth Airway Care The use of telehealth treatment has significantly expanded in recent years. With telehealth tools, hybrid care models combine in-person and virtual visits. This same technology also connects doctors, bringing together specialists and community clinicians. Regional Centers of Excellence Multidisciplinary airway centers have proven effective for helping patients access specialty care. Airway centers make it easier to streamline referrals in complex cases. These airway centers can serve larger geographic areas by setting up outreach clinics in surrounding communities. Collaborative Networks Partnerships and collaborations between physicians are key to ensuring that primary care providers in underserved areas have access to resources and information. Supporting Rural Physicians There are many ways to support rural physicians. Snot Force has committed to build networks for physicians, helping to ensure the dissemination of information across specialties and practice settings. We facilitate collaboration between disciplines to promote innovation in care for underserved communities. We're bringing doctors together to break down specialty care disparities and improve rural ENT access and information. Our research collaborative depends on many medical professionals to participate, and we're always looking for more physicians to join the force. To learn more, contact Snot Force today .